Turning cancer on
itself > Finally

SCINTIXTM therapy detects and responds to signals emitted from the cancer itself and, for the first time, uses them to guide immediate treatment. 


Cancer is talking.
We’re listening.

When PET radiotracers are introduced into the body, cancer cells absorb them and create a biological beacon, which our machine uses to track and treat solid tumors of any stage disease. 

Learn More About Emissions

Targeting Cancer


Our SCINTIX technology delivers high doses of radiation to tumors, even those in motion. Live targeting allows for greater impact to the tumor and potentially less dose to surrounding tissues.

Learn About Targeting


A world where stage is just a number.

Most patients with stage four cancer are not considered candidates for definitive radiotherapy. Our breakthrough SCINTIX technology creates a new opportunity for patients at any stage of cancer.

Discover the Potential

Combination Treatment

Come at cancer from every angle.

Treatment isn’t a one-size-fits-all situation. For many patients, the best treatment plan is a combination of multiple therapies. SCINTIX therapy may work together with chemotherapy, immunotherapy and targeted drugs for potentially better outcomes.

Learn About Treatment

Learn more about our breakthrough technology

SCINTIX Biology-guided Radiotherapy

By combining PET-CT and radiotherapy, we're able to find and treat cancer using its own emissions.


Discover SCINTIX therapy.

Cancer Centers

See how SCINTIX therapy can play a role
in your cancer program.

Make every day count

See Available Positions


Press Releases

RefleXion Wins 2022 Pantheon Award from California Life Sciences

19th Annual Pantheon Awards celebrate excellence in California’s life sciences sector HAYWARD, Calif., Nov. 4, 2022 – RefleXion Medical, a therapeutic oncology company pioneering SCINTIX™ biology-guided radiotherapy*, a new modality for treating all stages of cancer, announced today that California Life Sciences (CLS), the state’s largest and most influential life sciences organization, has awarded it […]

View All Press chevron right


Fresh $80M Round Aims to Help East Bay Company Zap Cancer

Sam Mazin wandered into a lecture at Stanford University 15 years ago, and today his company said it walked away with $80 million for a machine aimed at zapping tough-to-treat, late-stage cancers.

View All News chevron right


RefleXion Highlights at ASTRO 2022: SCINTIX Therapy, Science and Sharing

Booth #3745 in the exhibit hall at ASTRO’s annual conference in San Antonio, Texas, was bustling with activity. Thousands of radiation oncologists convene at ASTRO each year to learn and share advances in radiotherapy planning and treatment. Conference attendees stopped by to ask questions and watch demonstrations of RefleXion Medical’s X1 platform. For the first […]

View All Blog Posts chevron right


Let us tell you more.

Contact Us

Sign up for our
latest news and information.

Stay up to date.

Sign Up